 
				 
										
USFDA APPLICATION NUMBER - 80028 / DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 10%
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength | 
|---|---|---|
| sulfacetamide sodium(UNII: 4NRT660KJQ) (sulfacetamide - UNII:4965G3J0F5) | sulfacetamide sodium | 100mg in 1 | 
Inactive Ingredients
| Ingredient Name | Allergan, Inc. | Pacific Pharma, Inc. | Akorn, Inc. | Lake Erie Medical DBA Quality Care Products LLC | REMEDYREPACK INC.  | NuCare Pharmaceuticals,Inc. | Preferred Pharmaceuticals Inc. | 
|---|---|---|---|---|---|---|---|
| benzalkonium chloride(F5UM2KM3W7) | |||||||
| edetate disodium(7FLD91C86K) | |||||||
| hydrochloric acid(QTT17582CB) | |||||||
| Hypromelloses(3NXW29V3WO) | |||||||
| METHYLCELLULOSE (100 CPS)(4GFU244C4J) | |||||||
| METHYLCELLULOSE (4000 CPS)(MRJ667KA5E) | |||||||
| METHYLCELLULOSE (4000 MPA.S)(MRJ667KA5E) | |||||||
| Methylparaben(A2I8C7HI9T) | |||||||
| polysorbate 80(6OZP39ZG8H) | |||||||
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |||||||
| Propylparaben(Z8IX2SC1OH) | |||||||
| sodium hydroxide(55X04QC32I) | |||||||
| sodium phosphate, dibasic(GR686LBA74) | |||||||
| sodium phosphate, dibasic, anhydrous(22ADO53M6F) | |||||||
| sodium phosphate, monobasic(3980JIH2SW) | |||||||
| SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM(3980JIH2SW) | |||||||
| SODIUM THIOSULFATE(HX1032V43M) | |||||||
| WATER(059QF0KO0R) |